Theravance anticipates $150M in milestones as CYPRESS trial nears pivotal data readout Theravance anticipates $150M in milestones as CYPRESS trial nears pivotal data readout Post ContenttbphRead More You might also be interested in reading XRP Breaks 2026 Low as $1 Test Opens 57% Risk to $0.43. August 12, 2025 In Mainstream ← Previous post Next post →